These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 28273718)

  • 1. Mechanisms of Parkinson's disease-related proteins in mediating secondary brain damage after cerebral ischemia.
    Kim T; Vemuganti R
    J Cereb Blood Flow Metab; 2017 Jun; 37(6):1910-1926. PubMed ID: 28273718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease.
    Büeler H
    Exp Neurol; 2009 Aug; 218(2):235-46. PubMed ID: 19303005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microglia and astrocyte dysfunction in parkinson's disease.
    Kam TI; Hinkle JT; Dawson TM; Dawson VL
    Neurobiol Dis; 2020 Oct; 144():105028. PubMed ID: 32736085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Parkinson's disease: what have we learned from the genes responsible for familial forms?].
    Corti O; Brice A
    Med Sci (Paris); 2003 May; 19(5):613-9. PubMed ID: 12836396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parkinson's disease proteins: Novel mitochondrial targets for cardioprotection.
    Mukherjee UA; Ong SB; Ong SG; Hausenloy DJ
    Pharmacol Ther; 2015 Dec; 156():34-43. PubMed ID: 26481155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mitochondrial dysfunction and oxidative damages in the molecular pathology of Parkinson's disease].
    Shadrina MI; Slominskiĭ PA
    Mol Biol (Mosk); 2008; 42(5):809-19. PubMed ID: 18988530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The regulatory role of α-synuclein and parkin in neuronal cell apoptosis; possible implications for the pathogenesis of Parkinson's disease.
    Yasuda T; Mochizuki H
    Apoptosis; 2010 Nov; 15(11):1312-21. PubMed ID: 20221696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of oxidative stress in Parkinson's disease.
    Dias V; Junn E; Mouradian MM
    J Parkinsons Dis; 2013; 3(4):461-91. PubMed ID: 24252804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hinokitiol Offers Neuroprotection Against 6-OHDA-Induced Toxicity in SH-SY5Y Neuroblastoma Cells by Downregulating mRNA Expression of MAO/α-Synuclein/LRRK2/PARK7/PINK1/PTEN Genes.
    Varier KM; Sumathi T
    Neurotox Res; 2019 May; 35(4):945-954. PubMed ID: 30569287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysregulated Interorganellar Crosstalk of Mitochondria in the Pathogenesis of Parkinson's Disease.
    Sironi L; Restelli LM; Tolnay M; Neutzner A; Frank S
    Cells; 2020 Jan; 9(1):. PubMed ID: 31963435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inclusion body formation and neurodegeneration are parkin independent in a mouse model of alpha-synucleinopathy.
    von Coelln R; Thomas B; Andrabi SA; Lim KL; Savitt JM; Saffary R; Stirling W; Bruno K; Hess EJ; Lee MK; Dawson VL; Dawson TM
    J Neurosci; 2006 Apr; 26(14):3685-96. PubMed ID: 16597723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apoptosis in Parkinson's disease: is p53 the missing link between genetic and sporadic Parkinsonism?
    Alves da Costa C; Checler F
    Cell Signal; 2011 Jun; 23(6):963-8. PubMed ID: 20969953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of LRRK2 and α-Synuclein in Parkinson's Disease.
    Daher JP
    Adv Neurobiol; 2017; 14():209-226. PubMed ID: 28353286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Parkinson's disease-related genes act in mitochondrial homeostasis.
    Sai Y; Zou Z; Peng K; Dong Z
    Neurosci Biobehav Rev; 2012 Oct; 36(9):2034-43. PubMed ID: 22771336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cell biology of Parkinson's disease.
    Panicker N; Ge P; Dawson VL; Dawson TM
    J Cell Biol; 2021 Apr; 220(4):. PubMed ID: 33749710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pathogenesis of Parkinson's disease: implications from familial Parkinson's disease].
    Iwatsubo T; Ito G; Takatori S; Hannno Y; Kuwahara T
    Rinsho Shinkeigaku; 2005 Nov; 45(11):899-901. PubMed ID: 16447757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular insights into Parkinson's disease.
    Rochet JC; Hay BA; Guo M
    Prog Mol Biol Transl Sci; 2012; 107():125-88. PubMed ID: 22482450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parkinson's disease.
    Thomas B; Beal MF
    Hum Mol Genet; 2007 Oct; 16 Spec No. 2():R183-94. PubMed ID: 17911161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of posttranslational modifications of α-synuclein and LRRK2 in Parkinson's disease: Potential contributions of environmental factors.
    Pajarillo E; Rizor A; Lee J; Aschner M; Lee E
    Biochim Biophys Acta Mol Basis Dis; 2019 Aug; 1865(8):1992-2000. PubMed ID: 30481588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on the genetics of Parkinson's disease.
    Gasser T
    Mov Disord; 2007 Sep; 22 Suppl 17():S343-50. PubMed ID: 18175395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.